American Society of Clinical Oncology

SHERPA: White

People

  1. Lesokhin
    Lesokhin
  2. Panageas
    Panageas
  3. Scheinberg
    Scheinberg
  4. Derkach
    Derkach
  5. Hassoun
    Hassoun
  6. Hultcrantz
    Hultcrantz
  7. Korde
    Korde
  8. Mailankody
    Mailankody
  9. Shah
    Shah
  10. Giralt
    Giralt

Groups

  1. Biostatistics Service (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Epidemiology and Biostatistics (17)
  5. Hematologic Malignancies Research (17)
  6. Hematologic Malignancies, Division of (14)
  7. GSK Faculty (11)
  8. Population Sciences Research Program (11)
  9. Sloan Kettering Institute Faculty (9)
  10. Molecular Pharmacology and Chemistry Program Faculty (8)
Search Within
  1. "Biostatistics Service"
  2. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
Groups
  1. Biostatistics Service (17)
  2. Center for Hematologic Malignancies (17)
  3. Department of Medicine (17)
  4. Epidemiology and Biostatistics (17)
  5. Hematologic Malignancies Research (17)
  6. Hematologic Malignancies, Division of (14)

More Groups

People
  1. Alexander Lesokhin (7)
  2. David Scheinberg (6)
  3. Katherine Panageas (6)
  4. Andriy Derkach (5)
  5. Hani Hassoun (5)
  6. Malin Hultcrantz (5)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (2)
  6. 2016 (2)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. JCO Precision Oncology (1)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
    Meeting Abstract

    Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: Molecular remissions predict for durable complete responses
    Journal Article

    Lamanna, N.; Jurcic, J. G.; Noy, A.; Maslak, P.; Gencarelli, A. N.; Panageas, K. S.; Heaney, M. L.; Brentjens, R. J.; Golde, D. W.; Scheinberg, D. A.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Association of MBL2 genotypes wtih infections and outcome after allogeneic stem cell transplantation
    Meeting Abstract

    Papanicolaou, G. A.; Mihu, C.; Kadeishvili, K.; Doll, M.; Stokar, D.; Buchbinder, A.; Hsu, K.; O'Reilly, R.; Pamer, E. G.; Satagopan, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
    Journal Article

    Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A randomized trial of cytarabine with high-dose mitoxantrone compared to a standard vincristine/prednisone-based regimen as induction therapy for adult patients with ALL
    Meeting Abstract

    Weiss, M. A.; Heffner, L.; Lamanna, N.; Kalaycio, M.; Schiller, G.; Coutre, S.; Maslak, P.; Jurcic, J.; Panageas, K.; Scheinberg, D. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxide
    Journal Article

    Camacho, L. H.; Soignet, S. L.; Chanel, S.; Ho, R.; Heller, G.; Scheinberg, D. A.; Ellison, R.; Warrell, R. P.
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save